| Name | 2-butyl-5-chloro-3-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid |
|---|---|
| Synonyms |
2-butyl-4-chloro-1-[2'-(1-triphenylmethyl-tetrazol-5-yl)1,1'-biphenyl-methyl]imidazole-5-carboxylic acid
2-butyl-4-chloro-1-{[2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid N-Trityl Losartan Carboxylic Acid 2-butyl-4-chloro-1-[2'-(1-triphenylmethyl-1H-tetrazol-5-yl)-biphenyl-4ylmethyl]-1H-imidazole-5-carboxylic acid 2-Butyl-4-chloro-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid 2-butyl-4-chloro-1-[2'-(1-trityl-1H-tetrazol-5-yl)-1,1'-biphenyl-4-ylmethyl]-imidazole-5-carboxylic acid |
| Density | 1.25g/cm3 |
|---|---|
| Boiling Point | 875.2ºC at 760 mmHg |
| Molecular Formula | C42H37ClN6O3 |
| Molecular Weight | 709.23500 |
| Flash Point | 483.1ºC |
| Exact Mass | 708.26200 |
| PSA | 107.95000 |
| LogP | 9.28270 |
| Index of Refraction | 1.664 |
|
~%
947331-10-4 |
| Literature: SHANGHAI ALLIST PHARMACEUTICAL., INC. Patent: EP1988090 A1, 2008 ; Location in patent: Page/Page column 11 ; EP 1988090 A1 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |